Genetic, immunological, and transcriptomic studies have implicated <i>CNTNAP2</i> in a broad spectrum of neurological and psychiatric disorders, autoimmune encephalitis, and cancer. This evidence concerns the gene CNTNAP2 and autoimmune encephalitis.